Maarten L. Janmaat

Response to epidermal growth factor receptor inhibitors in non-small cell lung cancer cells: limited antiproliferative effects and absence of apoptosis associated with persistent activity of extracellular signal-regulated kinase or Akt kinase pathways.

Maarten L. Janmaat, Frank A.E. Kruyt, José Antonio Rodríguez et al. · PubMed · 2003 · 328 citations

Persistent Activity, Cell Death, Extracellular Signal-regulated Kinase +17

Predictive Factors for Outcome in a Phase II Study of Gefitinib in Second-Line Treatment of Advanced Esophageal Cancer Patients

Maarten L. Janmaat, Mariëlle I. Gallegos-Ruiz, José Antonio Rodríguez et al. · Journal of Clinical Oncology · 2006 · 230 citations

Cooperative targeting of melanoma heterogeneity with an AXL antibody-drug conjugate and BRAF/MEK inhibitors

Julia Boshuizen, Louise A. Koopman, Oscar Krijgsman et al. · Nature Medicine · 2018 · 215 citations

Melanoma Heterogeneity, Axl Antibody-drug Conjugate, Drug Targeting +11

Enhanced cytotoxicity induced by gefitinib and specific inhibitors of the Ras or phosphatidyl inositol‐3 kinase pathways in non‐small cell lung cancer cells

Maarten L. Janmaat, José Antonio Rodríguez, Mariëlle I. Gallegos-Ruiz et al. · International Journal of Cancer · 2005 · 150 citations

Cell Death, Cancer Biology, Tumor Biology +18

Kahalalide F Induces Necrosis-Like Cell Death that Involves Depletion of ErbB3 and Inhibition of Akt Signaling

Maarten L. Janmaat, José Antonio Rodríguez, José Jimeno et al. · Molecular Pharmacology · 2005 · 111 citations